Review





Similar Products

anti-mmp13 a11148  (ABclonal Biotechnology)
90
ABclonal Biotechnology anti-mmp13 a11148
Senescence of NPCs is the main feature of IDD. a, Imaging characteristics of intervertebral discs on non-IDD or IDD patients on MRI; b, Alcian blue staining of NP tissues in non-IDD or IDD tissues; c, d, Protein expression of p21 in non-IDD or IDD tissues detected by Western blots; e, SA-β-gal staining of NPCs derived from non-IDD or IDD tissues; f, mRNA sequencing and Western blots to detect the mRNA and protein change between normal NPCs and senescent NPCs; g, PCA of differently expressed genes between normal NPCs and senescent NPCs; h, mRNA levels of extracellular matrix synthesis-related markers between normal and senescent NPCs, including COL2A1, ACAN, SOX9, ADAMTS5, <t>MMP13,</t> MMP3, and ADAMTS4; i, GSEA enrichment of differently expressed genes between normal and senescent NPCs; j,k, Protein levels of p21 between normal and senescent NPCs; l,m, EdU assay to detect the cell proliferation of normal and senescent NPCs; n,o, SA-β-gal staining of normal and senescent NPCs. ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001.
Anti Mmp13 A11148, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-mmp13 a11148/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
anti-mmp13 a11148 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
mmp13 a11148 antibody  (ABclonal Biotechnology)
90
ABclonal Biotechnology mmp13 a11148 antibody
Senescence of NPCs is the main feature of IDD. a, Imaging characteristics of intervertebral discs on non-IDD or IDD patients on MRI; b, Alcian blue staining of NP tissues in non-IDD or IDD tissues; c, d, Protein expression of p21 in non-IDD or IDD tissues detected by Western blots; e, SA-β-gal staining of NPCs derived from non-IDD or IDD tissues; f, mRNA sequencing and Western blots to detect the mRNA and protein change between normal NPCs and senescent NPCs; g, PCA of differently expressed genes between normal NPCs and senescent NPCs; h, mRNA levels of extracellular matrix synthesis-related markers between normal and senescent NPCs, including COL2A1, ACAN, SOX9, ADAMTS5, <t>MMP13,</t> MMP3, and ADAMTS4; i, GSEA enrichment of differently expressed genes between normal and senescent NPCs; j,k, Protein levels of p21 between normal and senescent NPCs; l,m, EdU assay to detect the cell proliferation of normal and senescent NPCs; n,o, SA-β-gal staining of normal and senescent NPCs. ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001.
Mmp13 A11148 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mmp13 a11148 antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
mmp13 a11148 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies mmp-13 a11148  (ABclonal Biotechnology)
90
ABclonal Biotechnology primary antibodies mmp-13 a11148
Senescence of NPCs is the main feature of IDD. a, Imaging characteristics of intervertebral discs on non-IDD or IDD patients on MRI; b, Alcian blue staining of NP tissues in non-IDD or IDD tissues; c, d, Protein expression of p21 in non-IDD or IDD tissues detected by Western blots; e, SA-β-gal staining of NPCs derived from non-IDD or IDD tissues; f, mRNA sequencing and Western blots to detect the mRNA and protein change between normal NPCs and senescent NPCs; g, PCA of differently expressed genes between normal NPCs and senescent NPCs; h, mRNA levels of extracellular matrix synthesis-related markers between normal and senescent NPCs, including COL2A1, ACAN, SOX9, ADAMTS5, <t>MMP13,</t> MMP3, and ADAMTS4; i, GSEA enrichment of differently expressed genes between normal and senescent NPCs; j,k, Protein levels of p21 between normal and senescent NPCs; l,m, EdU assay to detect the cell proliferation of normal and senescent NPCs; n,o, SA-β-gal staining of normal and senescent NPCs. ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001.
Primary Antibodies Mmp 13 A11148, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies mmp-13 a11148/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
primary antibodies mmp-13 a11148 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
antibody mmp13 a11148  (ABclonal Biotechnology)
90
ABclonal Biotechnology antibody mmp13 a11148
Senescence of NPCs is the main feature of IDD. a, Imaging characteristics of intervertebral discs on non-IDD or IDD patients on MRI; b, Alcian blue staining of NP tissues in non-IDD or IDD tissues; c, d, Protein expression of p21 in non-IDD or IDD tissues detected by Western blots; e, SA-β-gal staining of NPCs derived from non-IDD or IDD tissues; f, mRNA sequencing and Western blots to detect the mRNA and protein change between normal NPCs and senescent NPCs; g, PCA of differently expressed genes between normal NPCs and senescent NPCs; h, mRNA levels of extracellular matrix synthesis-related markers between normal and senescent NPCs, including COL2A1, ACAN, SOX9, ADAMTS5, <t>MMP13,</t> MMP3, and ADAMTS4; i, GSEA enrichment of differently expressed genes between normal and senescent NPCs; j,k, Protein levels of p21 between normal and senescent NPCs; l,m, EdU assay to detect the cell proliferation of normal and senescent NPCs; n,o, SA-β-gal staining of normal and senescent NPCs. ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001.
Antibody Mmp13 A11148, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibody mmp13 a11148/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
antibody mmp13 a11148 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Senescence of NPCs is the main feature of IDD. a, Imaging characteristics of intervertebral discs on non-IDD or IDD patients on MRI; b, Alcian blue staining of NP tissues in non-IDD or IDD tissues; c, d, Protein expression of p21 in non-IDD or IDD tissues detected by Western blots; e, SA-β-gal staining of NPCs derived from non-IDD or IDD tissues; f, mRNA sequencing and Western blots to detect the mRNA and protein change between normal NPCs and senescent NPCs; g, PCA of differently expressed genes between normal NPCs and senescent NPCs; h, mRNA levels of extracellular matrix synthesis-related markers between normal and senescent NPCs, including COL2A1, ACAN, SOX9, ADAMTS5, MMP13, MMP3, and ADAMTS4; i, GSEA enrichment of differently expressed genes between normal and senescent NPCs; j,k, Protein levels of p21 between normal and senescent NPCs; l,m, EdU assay to detect the cell proliferation of normal and senescent NPCs; n,o, SA-β-gal staining of normal and senescent NPCs. ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001.

Journal: Bioactive Materials

Article Title: Exosomes derived from MSCs exposed to hypoxic and inflammatory environments slow intervertebral disc degeneration by alleviating the senescence of nucleus pulposus cells through epigenetic modifications

doi: 10.1016/j.bioactmat.2025.02.046

Figure Lengend Snippet: Senescence of NPCs is the main feature of IDD. a, Imaging characteristics of intervertebral discs on non-IDD or IDD patients on MRI; b, Alcian blue staining of NP tissues in non-IDD or IDD tissues; c, d, Protein expression of p21 in non-IDD or IDD tissues detected by Western blots; e, SA-β-gal staining of NPCs derived from non-IDD or IDD tissues; f, mRNA sequencing and Western blots to detect the mRNA and protein change between normal NPCs and senescent NPCs; g, PCA of differently expressed genes between normal NPCs and senescent NPCs; h, mRNA levels of extracellular matrix synthesis-related markers between normal and senescent NPCs, including COL2A1, ACAN, SOX9, ADAMTS5, MMP13, MMP3, and ADAMTS4; i, GSEA enrichment of differently expressed genes between normal and senescent NPCs; j,k, Protein levels of p21 between normal and senescent NPCs; l,m, EdU assay to detect the cell proliferation of normal and senescent NPCs; n,o, SA-β-gal staining of normal and senescent NPCs. ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001.

Article Snippet: The tissue sections were incubated with the primary antibodies anti-MMP13 (1:300, A11148, ABclonal, China) at 4 °C overnight.

Techniques: Imaging, Staining, Expressing, Western Blot, Derivative Assay, Sequencing, EdU Assay

Hi-Exos alleviated the in vivo rat IDD through transferring the miR-221-3p to senescent NPCs. a, Schematic diagram of in vivo rat IDD experiments; b, H&E, SO&FG, and immumohistochemical staining (MMP13) of rat NP tissues after different exosome interventions for rat IDD; c,d, Histological score (c) and MMP13 protein level (d) of rat NP tissues after different exosome interventions for rat IDD. ∗∗∗∗P < 0.0001.

Journal: Bioactive Materials

Article Title: Exosomes derived from MSCs exposed to hypoxic and inflammatory environments slow intervertebral disc degeneration by alleviating the senescence of nucleus pulposus cells through epigenetic modifications

doi: 10.1016/j.bioactmat.2025.02.046

Figure Lengend Snippet: Hi-Exos alleviated the in vivo rat IDD through transferring the miR-221-3p to senescent NPCs. a, Schematic diagram of in vivo rat IDD experiments; b, H&E, SO&FG, and immumohistochemical staining (MMP13) of rat NP tissues after different exosome interventions for rat IDD; c,d, Histological score (c) and MMP13 protein level (d) of rat NP tissues after different exosome interventions for rat IDD. ∗∗∗∗P < 0.0001.

Article Snippet: The tissue sections were incubated with the primary antibodies anti-MMP13 (1:300, A11148, ABclonal, China) at 4 °C overnight.

Techniques: In Vivo, Transferring, Staining